Candriam SCA’s Globus Medical GMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.1M | Buy |
171,838
+22,783
| +15% | +$1.34M | 0.06% | 255 |
|
|
2025
Q1 | $10.9M | Buy |
149,055
+41,132
| +38% | +$3.01M | 0.07% | 226 |
|
|
2024
Q4 | $8.93M | Sell |
107,923
-9,766
| -8% | -$808K | 0.05% | 279 |
|
|
2024
Q3 | $8.42M | Buy |
117,689
+40,023
| +52% | +$2.86M | 0.05% | 289 |
|
|
2024
Q2 | $5.32M | Sell |
77,666
-13,126
| -14% | -$899K | 0.03% | 332 |
|
|
2024
Q1 | $4.87M | Buy |
90,792
+37,735
| +71% | +$2.02M | 0.03% | 345 |
|
|
2023
Q4 | $2.83M | Sell |
53,057
-3,574
| -6% | -$190K | 0.02% | 431 |
|
|
2023
Q3 | $2.81M | Sell |
56,631
-71,717
| -56% | -$3.56M | 0.02% | 399 |
|
|
2023
Q2 | $7.64M | Buy |
128,348
+48,774
| +61% | +$2.9M | 0.06% | 282 |
|
|
2023
Q1 | $4.15M | Buy |
79,574
+15,000
| +23% | +$782K | 0.03% | 407 |
|
|
2022
Q4 | $4.8M | Sell |
64,574
-15,000
| -19% | -$1.11M | 0.03% | 388 |
|
|
2022
Q3 | $4.74M | Sell |
79,574
-12,328
| -13% | -$734K | 0.03% | 388 |
|
|
2022
Q2 | $5.16M | Sell |
91,902
-17,444
| -16% | -$979K | 0.04% | 320 |
|
|
2022
Q1 | $8.07M | Buy |
109,346
+50,346
| +85% | +$3.71M | 0.05% | 282 |
|
|
2021
Q4 | $4.26M | Hold |
59,000
| – | – | 0.03% | 387 |
|
|
2021
Q3 | $4.52M | Buy |
59,000
+24,000
| +69% | +$1.84M | 0.03% | 418 |
|
|
2021
Q2 | $2.71M | Buy |
+35,000
| New | +$2.71M | 0.02% | 527 |
|
|
2017
Q2 | – | Sell |
-50,000
| Closed | -$1.48M | – | 711 |
|
|
2017
Q1 | $1.48M | Hold |
50,000
| – | – | 0.03% | 495 |
|
|
2016
Q4 | $1.24M | Hold |
50,000
| – | – | 0.03% | 476 |
|
|
2016
Q3 | $1.13M | Hold |
50,000
| – | – | 0.03% | 472 |
|
|
2016
Q2 | $1.19M | Sell |
50,000
-14,000
| -22% | -$334K | 0.03% | 403 |
|
|
2016
Q1 | $1.51M | Buy |
64,000
+28,000
| +78% | +$662K | 0.04% | 365 |
|
|
2015
Q4 | $1M | Buy |
+36,000
| New | +$1M | 0.03% | 385 |
|